Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 12;84(9):1277-1282.
doi: 10.1292/jvms.22-0144. Epub 2022 Jul 29.

Malignant oligoastrocytoma in the spinal cord of a cat

Affiliations

Malignant oligoastrocytoma in the spinal cord of a cat

Dai Hasegawa et al. J Vet Med Sci. .

Abstract

A 12-year and 3-month spayed female mixed cat was presented with severe lumbar pain. Magnetic resonance imaging and postmortem examination revealed a swollen lesion in the spinal cord at L3 level. Histologic examination identified extensive neoplastic cell proliferation with massive necrosis in the tumor tissue. Two types of neoplastic cells were recognized. One type of neoplastic cells were large cells characterized by round to polygonal shape and abundant eosinophilic cytoplasm (referred to as "large cells"). The other neoplastic cells were small, densely proliferated, and had round to irregular shape and scant eosinophilic cytoplasm (referred to as "small cells"). Both types of cells were positive for oligodendrocyte transcription factor 2 and SRY-box transcription factor 10. Glial fibrillary acidic protein was positive in large cells but negative in most small cells. Digital analysis for Ki-67-stained tumor tissues found that total 21.1% ± 6.5% of tumor cells were positive for Ki-67. Based on these findings, we diagnosed malignant oligoastrocytoma in the spinal cord.

Keywords: Ki-67; cat; oligoastrocytoma; spinal cord; tumor.

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. The authors received no financial support for the research, authorship, and/or publication of this article.

Figures

Fig. 1.
Fig. 1.
MRI and gross images of the lumbar spinal cord. (A) T1-weighed MRI planes of the spinal cord following contrast administration. Arrow heads indicate the mass lesion. Left: coronal. Middle: sagittal. Right: axial. (B) Gross images of dorsal (left) and ventral (right) side of the spinal cord. Arrows indicate the swollen lesion. Bars=1 cm. R=right, L=left, Cr=cranial, Ca=caudal.
Fig. 2.
Fig. 2.
Hematoxylin and eosin staining of the mass in the lumbar spinal cord. (A) The subgross image of the lumbar spinal cord. The asterisk indicates the necrotic area. (B–D) High magnification of the tumor tissues. Insets show large cells (B) and small cells (C). Arrows in D indicate newly formed blood vessels. D=dorsal, V=ventral, R=right, L=left. Scale bars=1 mm (A), 20 µm (B–D).
Fig. 3.
Fig. 3.
Immunohistochemistry of the mass in the lumbar spinal cord. (A–F) Representative images (A, C, E) and signal intensities (B, D, F) of oligodendrocyte transcription factor 2 (OLIG2), SRY-box transcription factor 10 (SOX10) and glial fibrillary acidic protein (GFAP) staining. (G) Representative images of Ki-67. (H and I) Ki-67 expression profiles in all tumor cells (H) and in each tumor cell type (I). The graphs were created based on the average percentages ± SD. Large=large cells, Small=small cells. Bars=20 µm.

Similar articles

Cited by

References

    1. Acs B, Pelekanou V, Bai Y, Martinez-Morilla S, Toki M, Leung SCY, Nielsen TO, Rimm DL. 2019. Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study. Lab Invest 99: 107–117. doi: 10.1038/s41374-018-0123-7 - DOI - PubMed
    1. Bankhead P, Loughrey MB, Fernández JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG, James JA, Salto-Tellez M, Hamilton PW. 2017. QuPath: Open source software for digital pathology image analysis. Sci Rep 7: 16878. doi: 10.1038/s41598-017-17204-5 - DOI - PMC - PubMed
    1. Bannykh SI, Stolt CC, Kim J, Perry A, Wegner M. 2006. Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas. J Neurooncol 76: 115–127. doi: 10.1007/s11060-005-5533-x - DOI - PubMed
    1. Dimou L, Simon C, Kirchhoff F, Takebayashi H, Götz M. 2008. Progeny of Olig2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex. J Neurosci 28: 10434–10442. doi: 10.1523/JNEUROSCI.2831-08.2008 - DOI - PMC - PubMed
    1. Ferletta M, Uhrbom L, Olofsson T, Pontén F, Westermark B. 2007. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B—induced gliomagenesis. Mol Cancer Res 5: 891–897. doi: 10.1158/1541-7786.MCR-07-0113 - DOI - PubMed